BR100 Decreased By (-0.98%)
BR30 Decreased By (-0.58%)
KSE100 Decreased By (-0.97%)
KSE30 Decreased By (-1.07%)
AGHA 7.70 Decreased By ▼ -0.11 (-1.41%)
BECO 5.16 Decreased By ▼ -0.05 (-0.96%)
BML 56.60 Decreased By ▼ -0.90 (-1.57%)
BOP 33.82 Decreased By ▼ -0.21 (-0.62%)
CNERGY 9.95 Decreased By ▼ -0.01 (-0.1%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.07 Decreased By ▼ -1.63 (-2.98%)
FFL 16.58 Decreased By ▼ -0.11 (-0.66%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 7.27 Decreased By ▼ -0.13 (-1.76%)
KOSM 5.73 Decreased By ▼ -0.04 (-0.69%)
LOTCHEM 29.55 Increased By ▲ 0.23 (0.78%)
MLCF 92.90 Decreased By ▼ -1.46 (-1.55%)
NBP 202.00 Decreased By ▼ -1.05 (-0.52%)
NCPL 56.84 Decreased By ▼ -0.16 (-0.28%)
NPL 66.62 Decreased By ▼ -1.08 (-1.6%)
OGDC 318.98 Increased By ▲ 3.14 (0.99%)
PACE 10.55 Decreased By ▼ -0.09 (-0.85%)
PAEL 42.31 Decreased By ▼ -0.89 (-2.06%)
PIBTL 16.39 Decreased By ▼ -0.35 (-2.09%)
PPL 218.50 Decreased By ▼ -1.28 (-0.58%)
PRL 51.20 Increased By ▲ 2.01 (4.09%)
PTC 70.00 Decreased By ▼ -0.53 (-0.75%)
SSGC 26.96 Decreased By ▼ -1.29 (-4.57%)
TBL 9.75 Decreased By ▼ -0.11 (-1.12%)
TELE 8.68 Decreased By ▼ -0.11 (-1.25%)
TPL 17.99 Decreased By ▼ -0.25 (-1.37%)
TPLP 13.44 Increased By ▲ 0.17 (1.28%)
TREET 22.55 Decreased By ▼ -0.17 (-0.75%)
TRG 59.48 Decreased By ▼ -0.66 (-1.1%)
Business & Finance

Germany expects 40.2mn doses of Biontech COVID vaccine in Q2

  • The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday.
Published Updated
By

BERLIN: The German government expects 40.2 million doses of Biontech/Pfizer's COVID-19 vaccine in the second quarter, a government document seen by Reuters on Monday showed.

The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday, also said that the government sees potential delivery and production risks.

Comments

Comments are closed for this article.